South Korea

Celltrion Pharm (068760)

Track

Track

Ticker: 068760 Exchange: KOREA
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
I Eon Hyeong (이언형) Director (이사) Director
Transaction date
Purchase
Price
468.92
Quantity 54,408
Value ₩2,604,173
Choe Seung Jae (최승재) Unclassified position (전무) Officer
Transaction date
Purchase
Price
235.67
Quantity 62,494 +27.4%
Value ₩1,966,523
Gwon Hyeok Seong (권혁성) Director (이사) Director
Transaction date
Purchase
Price
45.83
Quantity 48,336 +39.1%
Value ₩1,835,578
Chae Ho Jin (채호진) Unclassified position (전무) Officer
Transaction date
Purchase
Price
10,742.00
Quantity 15,763 +263.3%
Value ₩169,326,146
Choe Eun Seok (최은석) Unclassified position (상무) Officer
Transaction date
Purchase
Price
10,742.00
Quantity 9,763 +60.5%
Value ₩104,874,146
Gim U Seong (김우성) Director (이사) Director
Transaction date
Purchase
Price
10,742.00
Quantity 3,000 +2419.4%
Value ₩32,226,000
Yun Tae Sik (윤태식) Unclassified position (이 사) Officer
Transaction date
Purchase
Price
10,742.00
Quantity 4,729 +18188.5%
Value ₩50,798,918
Gim Tae Jin (김태진) Director (이사) Director
Transaction date
Purchase
Price
10,742.00
Quantity 4,729 +44.7%
Value ₩50,798,918
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-10-24 2017-10-17 B Purchase I Eon Hyeong (이언형)

Director (이사)

Director
54,408
468.92
₩2,604,173 		54,408 468.92 ₩2,604,173
2017-10-24 2017-10-17 B Purchase Choe Seung Jae (최승재)

Unclassified position (전무)

Officer
62,494 +27.4%
235.67
₩1,966,523 		62,494 +27.4% 235.67 ₩1,966,523
2017-10-24 2017-10-17 B Purchase Gwon Hyeok Seong (권혁성)

Director (이사)

Director
48,336 +39.1%
45.83
₩1,835,578 		48,336 +39.1% 45.83 ₩1,835,578
2017-10-24 2017-10-17 B Purchase Chae Ho Jin (채호진)

Unclassified position (전무)

Officer
15,763 +263.3%
10,742.00
₩169,326,146 		15,763 +263.3% 10,742.00 ₩169,326,146
2017-10-24 2017-10-17 B Purchase Choe Eun Seok (최은석)

Unclassified position (상무)

Officer
9,763 +60.5%
10,742.00
₩104,874,146 		9,763 +60.5% 10,742.00 ₩104,874,146
2017-10-24 2017-10-17 B Purchase Gim U Seong (김우성)

Director (이사)

Director
3,000 +2419.4%
10,742.00
₩32,226,000 		3,000 +2419.4% 10,742.00 ₩32,226,000
2017-10-24 2017-10-17 B Purchase Yun Tae Sik (윤태식)

Unclassified position (이 사)

Officer
4,729 +18188.5%
10,742.00
₩50,798,918 		4,729 +18188.5% 10,742.00 ₩50,798,918
2017-10-24 2017-10-17 B Purchase Gim Tae Jin (김태진)

Director (이사)

Director
4,729 +44.7%
10,742.00
₩50,798,918 		4,729 +44.7% 10,742.00 ₩50,798,918
Explore more

More insider trading research around Celltrion Pharm

More insider trades in South Korea
Insider trading in Asia-Pacific